Clinical Research Detail Title Of Study EGF106708 : Phase-III trial with adjuvant treatment of patients with ErbB2 overexpressing and/or amplified breast cancer who have undegone masectomy and have received at least four cycles of an approved anthracycline-based (neo-) adjuvant chemotherapy regimen. Disease Condition Breast cancer Phase of Trial Phase-3 Discipline Oncology Start date of Trial 5/16/2007 Closing Date of Trial 5/16/2007 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]